‡ In these countries please contact our distributor

A - Assess

The products used in the T.I.M.E. clinical decision support tool may vary in different markets.  Not all products referred to may be approved for use or available in all markets.  Please consult your local Smith & Nephew representative for further details on products available in your market.
Intended for healthcare professionals outside of the US only.



…patient, wellbeing and wound

According to international consensus, accurate, holistic assessment is essential to inform treatment choice and to track wound progress1. To optimise wound bed preparation, an appropriate practitioner should consider the following:

  • Establish diagnosis and baseline characteristics.
  • Make a record of the wound type, location and size.
  • Note the wound bed condition.
  • Check for signs of infection or inflammation, ideally through accurate wound visualisation.
  • Consult the patient on pain levels and intensity, relevant systemic conditions and comorbidities.
  • Considerations for adherence to treatment.

See what you’re dealing with

The MolecuLight i:XTM Imaging Device supports clinical judgment, facilitating precise debridement and guiding treatment decisions2,3.

The MolecuLight i:XTM device assists clinicians during routine clinical wound assessment processes, supporting more responsible antimicrobial stewardship and antibiotics decision-making4-8 >  

Next step > Bring in other healthcare professionals


Helping you get CLOSER TO ZERO delay in wound healing.


A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Smith & Nephew does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it on patients.



1) International consensus. Optimising wellbeing in people living with a wound. An expert working group review. London: Wounds International, 2012.
2) DaCosta RS, Kulbatski I, Lindvere-Teene L, Starr D, Blackmore K, Silver JI, Opoku J, Wu YC, Medeiros PJ, Xu W, et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015 Mar 19;10(3).
3) MolecuLight Inc. PN 1281 MolecuLight i:X Executive Summary. 2016.
4) Wu YC, Smith M, Chu A, Lindvere-Teene L, Starr D, Tapang K, Wong O, Linden R, DaCosta RS. Handheld fluorescence imaging device detects subclinical wound infection in an asymptomatic patient with chronic diabetic foot ulcer: a case report. Int Wound J. 2016 Aug;13(4):449-53.
5) Raizman R. Point-of-care fluorescence imaging device guides care and patient education in obese patients with surgical site infections. Presented at: CAWC 2016. Proceedings of the 22nd Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON.
6) Raizman R. Fluorescence imaging positively predicts bacterial presence and guides wound cleaning and patient education in a series of pilonidal sinus patients. Proceedings of the Annual Wounds UK Conference; 2016 Nov 14-16; Harrogate, UK.
7) Hill R and Douglas JJ. Real-time bacterial fluorescence imaging guides antimicrobial stewardship in patients with diverse wounds. Proceedings of the Annual Symposium on Advanced Wound Care (SAWC); 2017 Apr 5-9; San Diego, CA. (accepted).
8) Landis SJ. Mapping venous ulcers using bacterial autofluorescence (BAF) to identify subgroups at risk of infection post debridement. Proceedings of the Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON